A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma

Inclusion Criteria: * Availability for the entire study period and willingness to adhere to protocol requirements. * Diagnosis of multiple myeloma and eligible for receiving Doxorubicin liposome * 18 years of age or older * No evidence of underlying disease (except multiple myeloma) Exclusion Criteria: * History or presence of significant allergy or significant history of hypersensitivity or idiosyncratic reactions to doxorubicin hydrochloride * History of cardiovascular, pulmonary, hepatic, renal, gastrointestinal, endocrine, immunologic,dermatologic, musculoskeletal, neurological or psychiatric disease. * History of smoking (≥ 10 cigarettes/day) or consumption of tobacco products (≥ 4 chews/day). * Positive result to HIV, HCV, RPR and HBsAg.